Bone-derived growth factors modulate collagenase and TIMP (tissue inhibitor of metalloproteinases) activity and type I collagen degradation by mouse calvarial osteoblasts
- 31 January 1991
- journal article
- Published by Elsevier in Bone and Mineral
- Vol. 12 (1) , 41-55
- https://doi.org/10.1016/0169-6009(91)90120-o
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascadeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-IIBiochimica et Biophysica Acta (BBA) - General Subjects, 1988
- Isolation and characterization of insulin-like growth factor-II from human boneBiochemical and Biophysical Research Communications, 1988
- Degradation of type I collagen films by mouse osteoblasts is stimulated by 1,25 dihydroxyvitamin D3 and inhibited by human recombinant TIMP (tissue inhibitor of metalloproteinases)Biochemical and Biophysical Research Communications, 1987
- Mammalian collagenase predisposes bone surfaces to osteoclastic resorptionCell and tissue research, 1985
- Mouse osteoblasts synthesize collagenase in response to bone resorbing agentsBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Synthesis of collagenase and collagenase inhibitors by osteoblast-like cells in cultureEuropean Journal of Biochemistry, 1984
- IMMUNOCYTOCHEMICAL LOCALIZATION OF COLLAGENASE IN ISOLATED MOUSE BONE CELLS Biomedical Research, 1984
- The coupling of bone formation to bone resorption: A critical analysis of the concept and of its relevance to the pathogenesis of osteoporosisMetabolic Bone Disease and Related Research, 1982
- Normal osteoid tissueJournal of Clinical Pathology, 1972